Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brachial plexopathy associated with systemic sclerosis.

Y Allanore1, M Zuber, A Kahan

  • 1Cochin Hospital, Assistance Publique Hôpitaux de Paris, René Descartes University, France. yannick.allanore@cch.ap-hop-paris.fr

Clinical Rheumatology
|September 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study.

Seminars in arthritis and rheumatism·2018
Same author

Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.

Clinical and experimental rheumatology·2014
Same author

Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

[The minute structure of the macula region in connection with function tests in tapetoretinal degeneration].

A.M.A. archives of ophthalmology·2014
Same author

[Problem of early diagnosis in rheumatic diseases; changes in the leukogram and V.S.H. after intradermal injection of streptococcic antigen].

Probleme de reumatologie·2014
Same author

[Prevention of rheumatic diseases in school-age children].

Probleme de reumatologie·2014
Same journal

Extension of cytokines' role in Behcet's disease associated peripheral neuropathy.

Clinical rheumatology·2026
Same journal

Renal osteodystrophy with near-complete bilateral sacroiliac ankylosis: a bat-like pelvic configuration on CT.

Clinical rheumatology·2026
Same journal

Serum exosomal tRNA-derived small RNAs as diagnostic biomarkers for primary Sjögren's syndrome: a combined model with autoantibodies.

Clinical rheumatology·2026
Same journal

Monosodium urate crystals induce lytic macrophage death partially dependent on both pyroptosis and necroptosis.

Clinical rheumatology·2026
Same journal

A kaleidoscopic autoimmune syndrome (COVAS) following COVID-19 exposure.

Clinical rheumatology·2026
Same journal

Risk of arrhythmia following ankylosing spondylitis, 2012-2023: a nationwide cohort study.

Clinical rheumatology·2026
See all related articles

Systemic sclerosis rarely affects the nervous system. This case study details brachial plexopathy, a rare neurological complication, which improved with cyclophosphamide treatment.

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Background:

  • Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis and vascular abnormalities.
  • Neurological involvement in SSc is infrequent, typically presenting as trigeminal neuropathy or peripheral nerve entrapment.

Observation:

  • This report details a rare case of brachial plexopathy in a patient diagnosed with systemic sclerosis.
  • The brachial plexopathy was suspected to be a manifestation of vasculitis associated with SSc.

Findings:

  • The patient's brachial plexopathy demonstrated improvement following treatment with cyclophosphamide.
  • This represents the third reported instance of brachial plexopathy in the context of systemic sclerosis.

Implications:

Related Experiment Videos

  • This case highlights the potential for vasculitis to cause brachial plexopathy in SSc patients.
  • Cyclophosphamide may be an effective therapeutic option for managing this rare neurological complication in systemic sclerosis.